MiNK Therapeutics, Inc. — All Filings
239 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001171843-25-003207 | May 15, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-061041 | Apr 30, 2025 | Dec 31, 2024 |
| ARS | ARS | 0000950170-25-061188 | Apr 30, 2025 | Dec 31, 2024 |
| PRE 14A | PRE 14A | 0000950170-25-055881 | Apr 18, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001171843-25-001513 | Mar 18, 2025 | — |
| 10-K | 10-K | 0000950170-25-041379 | Mar 18, 2025 | Dec 31, 2024 |
| 4 | 4 | 0000950170-25-033525 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033522 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033528 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033540 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033523 | Mar 5, 2025 | Mar 3, 2025 |
| 8-K | 8-K | 0001193125-25-009595 | Jan 21, 2025 | Jan 17, 2025 |
| DEF 14A | DEF14A | 0001140361-24-050096 | Dec 20, 2024 | Jan 17, 2025 |
| 4 | 4 | 0000950170-24-134524 | Dec 9, 2024 | Oct 30, 2024 |
| 3 | 3 | 0000950170-24-134507 | Dec 9, 2024 | Oct 30, 2024 |
| PRE 14A | PRE14A | 0001140361-24-048693 | Dec 6, 2024 | Jan 17, 2025 |
| 4 | 4 | 0000950170-24-132524 | Dec 3, 2024 | Dec 1, 2024 |
| 4 | 4 | 0000950170-24-132525 | Dec 3, 2024 | Dec 1, 2024 |
| 4 | 4 | 0000950170-24-132518 | Dec 3, 2024 | Dec 1, 2024 |
| 4 | 4 | 0000950170-24-132520 | Dec 3, 2024 | Dec 1, 2024 |
| 10-Q | 10-Q | 0000950170-24-127033 | Nov 14, 2024 | Sep 30, 2024 |
| 8-K | FORM 8-K | 0001171843-24-006360 | Nov 14, 2024 | — |
| 8-K | 8-K | 0000950170-24-119270 | Oct 31, 2024 | Oct 30, 2024 |
| 8-K | 8-K | 0000950170-24-115596 | Oct 18, 2024 | Oct 15, 2024 |
| 8-K | 8-K | 0000950170-24-106345 | Sep 13, 2024 | — |
| 4 | 4 | 0000950170-24-103749 | Sep 5, 2024 | Sep 3, 2024 |
| 4 | 4 | 0000950170-24-103750 | Sep 5, 2024 | Sep 3, 2024 |
| 4 | 4 | 0000950170-24-103740 | Sep 5, 2024 | Sep 3, 2024 |
| 4 | 4 | 0000950170-24-103745 | Sep 5, 2024 | Sep 3, 2024 |
| 8-K | 8-K | 0000950170-24-102321 | Aug 30, 2024 | Aug 27, 2024 |
| EFFECT | — | 9999999995-24-002571 | Aug 16, 2024 | — |
| 424B3 | 424B3 | 0001193125-24-202168 | Aug 16, 2024 | — |
| UPLOAD | — | 0000000000-24-009341 | Aug 15, 2024 | — |
| CORRESP | — | 0001193125-24-201272 | Aug 15, 2024 | — |
| S-3 | S-3 | 0001193125-24-199818 | Aug 13, 2024 | — |
| 8-K | FORM 8-K | 0001171843-24-004721 | Aug 13, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-096142 | Aug 13, 2024 | Jun 30, 2024 |
| S-8 | S-8 | 0001193125-24-199792 | Aug 13, 2024 | — |
| 8-K | 8-K | 0000950170-24-074233 | Jun 17, 2024 | Jun 12, 2024 |
| 4 | 4 | 0000950170-24-069211 | Jun 5, 2024 | Jun 3, 2024 |
| 4 | 4 | 0000950170-24-069212 | Jun 5, 2024 | Jun 3, 2024 |
| 4 | 4 | 0000950170-24-069215 | Jun 5, 2024 | Jun 3, 2024 |
| 4 | 4 | 0000950170-24-069216 | Jun 5, 2024 | Jun 3, 2024 |
| SC 13G | GKCC LLC SCHEDULE 13G | 0001068238-24-000115 | May 22, 2024 | — |
| 8-K | 8-K | 0000950170-24-060805 | May 16, 2024 | May 13, 2024 |
| 10-Q | 10-Q | 0000950170-24-059081 | May 14, 2024 | Mar 31, 2024 |
| 8-K | FORM 8-K | 0001171843-24-002826 | May 14, 2024 | — |
| ARS | ARS | 0000950170-24-050088 | Apr 30, 2024 | Dec 31, 2023 |
| DEF 14A | DEF 14A | 0000950170-24-050064 | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | 10-K | 0000950170-24-034672 | Mar 21, 2024 | Dec 31, 2023 |